APA

Richel D. J., Johnsen H. E., Canon J., Guillaume T., Schaafsma M. R., Schenkeveld C., Hansen S. W., McNiece I., Gringeri A. J., Briddell R., Ewen C., Davies R., Freeman J., Miltenyi S. & Symann M. (20000411). Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. : Bone marrow transplantation.

Chicago

Richel D J, Johnsen H E, Canon J, Guillaume T, Schaafsma M R, Schenkeveld C, Hansen S W, McNiece I, Gringeri A J, Briddell R, Ewen C, Davies R, Freeman J, Miltenyi S and Symann M. 20000411. Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. : Bone marrow transplantation.

Harvard

Richel D. J., Johnsen H. E., Canon J., Guillaume T., Schaafsma M. R., Schenkeveld C., Hansen S. W., McNiece I., Gringeri A. J., Briddell R., Ewen C., Davies R., Freeman J., Miltenyi S. and Symann M. (20000411). Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. : Bone marrow transplantation.

MLA

Richel D J, Johnsen H E, Canon J, Guillaume T, Schaafsma M R, Schenkeveld C, Hansen S W, McNiece I, Gringeri A J, Briddell R, Ewen C, Davies R, Freeman J, Miltenyi S and Symann M. Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. : Bone marrow transplantation. 20000411.